Meet EIT Health Germany’s Regional Finalists for the European Health Catapult 2018
EIT Health Germany is pleased to introduce you to the 2018 German and Swiss regional finalists of the European Health Catapult 2018
On 11 July 2018, EIT Health Germany hosts the regional final for German and Swiss start-ups, the “Ship for Health Innovation Pitches (SHIP)” aboard the ship “Königin Silvia” in Heidelberg. Successful applicants in the field of biotech, medtech and digital health will be invited to the SHIP to pitch their business idea in front of a jury of entrepreneurs, industry partners and investors. The best two teams of each category will be nominated for the international pitch competition with the chance to become one of seven finalists in their category for the EIT Health Summit in Lodz, Poland.
The European Health Catapult (EHC) is a training and competition platform, jointly organized by EIT Health and Health Axis Europe, that includes several opportunities to present your company in front of experts and international investors. It awards the best-of-the-best business concepts from MedTech, BioTech and Digital Health across Europe.
Please find more information about the competing teams of EIT Health Germany’s European Health Catapult applicants 2018 below.
The teams of EIT Health Germany’s European Health Catapult 2018
- mk2 Biotechnologies
Memocorby is a neuroscientific-based, digital, multi-sensory tool for re-learning language for stroke patients or children with language problems, and for patients who suffer from dementia to maintain language, in a rapidly growing international healthcare market.
Sleepiz AG is a Zurich based award-winning Med-tech start-up founded by graduates from ETH Zurich and the University of St. Gallen (HSG), backed by leading sleep specialists in Switzerland. Sleepiz has developed a revolutionary sleep disorder screening device.
- Medical Magnesium
Targeted drugs are the new promising drug alternatives for cancer. However only 25% of cancer patients respond to drug therapy, even to these new targeted drugs. TherapySelect offers a commercial diagnostic product, whose technology can be used to solve the problem. The product is called CTR-Test (Chemotherapy-Resistance-Test).
Digital Health Startups
The “SHIP – Ship for Health Innovation Pitches” will be on 11 July 2018 in Heidelberg. Please register for the event by clicking the link below: